In May 2024, Novo Holdings, a Denmark-based company specializing in life science, acquired Catalent for a deal of $16.5 billion
Diagnosis is made by exclusion of alcohol abuse and other causes of liver disease (HBV-related hepatitis, HCV-related hepatitis, autoimmune liver diseases, polycystic ovary syndrome, drug-induced liver disease and congenital causes such as hereditary hemochromatosis, Wilsons disease, alpha-1 antitrypsin deficit)
They also have similar mechanisms of action, targeting GLP-1 to improve blood sugar control
While this has increased awareness, it has also created confusion
2017 Oct 7;390(10103):1664-1675
Vilsbll, T., Agers, H., Krarup, T